Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Phoenix Laser Systems

This article was originally published in The Gray Sheet

Executive Summary

Bernard Szeto, a member of an investor group that opposes the firm's proposed reorganization ("The Gray Sheet" April 19, p. 33), files suit in Delaware Court of Chancery "seeking injunctive relief, recision and damages based on allegations that Phoenix' management had, in violation of Delaware law, transferred all of Phoenix' assets to two new companies which would not be controlled by Phoenix," according to an April 19 Phoenix release. Phoenix maintains that "the lawsuit is without merit and will be defended vigorously." According to an April 14 Securities and Exchange Commission filing made by the investor group, Szeto filed a separate suit on March 29 in the Delaware court seeking to compel Phoenix to schedule an annual shareholders meeting. At the meeting, the investors would nominate "a slate of new directors" independent of Phoenix Chairman and CEO Steven Schiffer and would ask for a recision of transactions "related to the transfer of Phoenix assets to companies controlled by Mr. Schiffer." On April 6, Phoenix filed a suit against the investors in California Superior Court charging them with "misappropriation of funds" and acting in accordance with a plan to take over control of the firm.

You may also be interested in...

QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.

Novartis Logs Into India With Digital Innovation Hub

Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.

Rx List Price Inflation Penalty Endorsed By US HHS Secretary

Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts